Antidepressant (Celexa, Cymbalta, Effexor, Lexapro, Paxil, Prozac, SaraFem, Strattera, Wellbutrin, Zyban)
Anxiety, Delusions, Emotional Numbing, Hallucinations, Heart Attacks, Hostility, Mania, Panic Attacks, Paranoia, Seizures, Suicide, Violent Behavior.
Antipsychotics (Abilify, Haldol, Mellaril, Risperdal, Seroquel, Zuprexa)
Agitation, Anxiety, Cardiac Arrest, Depression, Diabetes, Fatal Blood Clots, Heart Failure, Hostility, Liver failure, Manic reaction, Suicidal Thoughts, Violence
Psychostimulants (Adderall, Concerta, Cylert, Dexedrine, Focalin, Metadate, Ritalin
Aggressive or hostile behavior, Agitation, Depression, Heart attack, Insomnia, Mania, Nervousness, Psychosis, Stroke, Stunted Growth, Sudden Death.
Why is this important? According to a study conducted by Medco Health Solutions. 1 in 5 Americans Now take at least one drug to treat a psychological disorder. And then the CDC states that HALF of Americans will suffer from mental health woes. When did being sad become a disease? When did being happy become a disease? Even more Scary: When did Feeling Becoming a Disorder?
If you are someone taking a medication for mental health...Please get the facts...Talk to a clinical psycologist who specializes in behavior rather than medication. Sometimes a good talk and a cry will do worlds of good. There are many psycologist and psychatrists availble who are willing to modify behavior first...medicate last.
Don't believe me on side-effects??? Take a Look at any Package Insert.
Here is a link to a Lutuda, which has a BLACK BOX warning: Here
Highlights ..Under Warnings and Precautions.:
Cerebrovascular Adverse Reactions in Elderly Patients with
Dementia-Related Psychosis: Increased incidence of
cerebrovascular adverse events (e.g., stroke, transient ischemic
Neuroleptic Malignant Syndrome: Manage with immediate
discontinuation and close monitoring (5.4).
Tardive Dyskinesia: Discontinue if clinically appropriate (5.5).
Metabolic Changes: Atypical antipsychotic drugs have been
associated with metabolic changes that may increase
cardiovascular/cerebrovascular risk. These metabolic changes
include hyperglycemia, dyslipidemia, and weight gain (5.6).
Hyperglycemia and Diabetes Mellitus: Monitor patients for
symptoms of hyperglycemia including polydipsia, polyuria,
polyphagia, and weakness. Monitor glucose regularly in
patients with diabetes or at risk for diabetes.
Dyslipidemia: Undesirable alterations have been observed in
patients treated with atypical antipsychotics.
Weight Gain: Gain in body weight has been observed.
Hyperprolactinemia: Prolactin elevations may occur (5.7).
Leukopenia, Neutropenia, and Agranulocytosis: Perform complete
blood counts (CBC) in patients with a pre-existing low white blood
cell count (WBC) or a history of leukopenia or neutropenia.
Consider discontinuing LATUDA if a clinically significant decline
in WBC occurs in the absence of other causative factors (5.8).
Orthostatic Hypotension and Syncope: Dizziness, tachycardia or
bradycardia, and syncope may occur, especially early in treatment.
In patients with known cardiovascular or cerebrovascular disease,
and in antipsychotic-naïve patients, consider a lower starting dose
and slower titration (5.9).